This compound is a pharmaceutical intermediate specifically used in the synthesis of finerenone. It is a substituted 1,4-dihydro-1,6-naphthyridine-3-carboxylic acid derivative containing cyano, methoxy, and ethoxy functional groups.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1050477-45-6
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
active pharmaceutical ingredient
Finérénone
mineralocorticoid receptor antagonist
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate
pharmaceutical intermediate
5-Desethoxy,-5-Methoxy-Finerenone
Mineralocorticoid receptor antagonist intermediate
2-Cyanoethyl (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxylate
pharmaceutical intermediate for finerenone
(S)-Ropivacaine N-Isopropyl
pharmaceutical intermediate for ropivacaine analogs
3,3'-(Biphenyl-4,4'-diylbis(oxy))dianiline
Pharmaceutical intermediate
2-cyclopropyl-7-(trideuteriomethyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
deuterated nevirapine intermediate
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid
CTEQWCKBTWAWIH-UHFFFAOYSA-N
CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)O)C3=C(C=C(C=C3)C#N)OC)C